Hein Park Capital Management LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Hein Park Capital Management LP disclosed 4 US equity positions worth $130.2m in its Q4 2024 13F filing. The largest position was DBD at 67.2% of the reported book, followed by SGRY and BHC. Against the Q3 2024 filing, it opened 1 new position, added to 0 and reduced 1 among the top 4 holdings.
What did Hein Park Capital Management LP own in Q4 2024? Top 4 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | DBD DIEBOLD NIXDORF INC | Technology | 67.2% | $87.5m | 2,033,104 | -25% | reduced |
| 2 | SGRY SURGERY PARTNERS INC | Healthcare | 18.5% | $24.1m | 1,139,227 | – | new |
| 3 | BHC BAUSCH HEALTH COS INC | Healthcare | 11.5% | $14.9m | 1,853,379 | -0% | held |
| 4 | HERTZ GLOBAL HLDGS INC | 2.8% | $3.6m | 1,683,087 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.